These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 9081731)

  • 1. [Severe immunodeficiency due to Jak 3 kinase deficiency].
    Boku S; Saijo K; Saito T
    Nihon Rinsho Meneki Gakkai Kaishi; 1996 Dec; 19(6):631-6. PubMed ID: 9081731
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunodeficiencies caused by genetic defects in protein kinases.
    Notarangelo LD
    Curr Opin Immunol; 1996 Aug; 8(4):448-53. PubMed ID: 8794005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SCID due to ZAP-70 deficiency.
    Elder ME
    J Pediatr Hematol Oncol; 1997; 19(6):546-50. PubMed ID: 9407944
    [No Abstract]   [Full Text] [Related]  

  • 4. [Report of a rare immunodeficiency, JAK-3 protein deficiency].
    Mbou FM; Cattelain N; Villatte P; Monlouis M; Elana G
    Arch Pediatr; 2001 Jun; 8(6):666-7. PubMed ID: 11446191
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe combined immune deficiencies due to defects of the common gamma chain-JAK3 signaling pathway.
    Candotti F; O'Shea JJ; Villa A
    Springer Semin Immunopathol; 1998; 19(4):401-15. PubMed ID: 9618765
    [No Abstract]   [Full Text] [Related]  

  • 6. Selection transduction defect (STD) due to Zap-70 kinase deficiency.
    Roifman CM
    Immunodeficiency; 1995; 5(3):193-211. PubMed ID: 7749439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells.
    Witthuhn BA; Silvennoinen O; Miura O; Lai KS; Cwik C; Liu ET; Ihle JN
    Nature; 1994 Jul; 370(6485):153-7. PubMed ID: 8022486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic effects on immunity. Protein tyrosine kinases: disease loci for inherited immunodeficiencies.
    Leonard WJ
    Curr Opin Immunol; 1997 Aug; 9(4):525-7. PubMed ID: 9287183
    [No Abstract]   [Full Text] [Related]  

  • 9. JAK3: a novel JAK kinase associated with terminal differentiation of hematopoietic cells.
    Rane SG; Reddy EP
    Oncogene; 1994 Aug; 9(8):2415-23. PubMed ID: 7518579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Severe combined immunodeficiency].
    Kumaki S; Tsuchiya S
    Ryoikibetsu Shokogun Shirizu; 2000; (32):38-42. PubMed ID: 11212751
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel mutation of intron 22 in Janus kinase 3-deficient severe combined immunodeficiency.
    Mjaanes CM; Hendershot RW; Quinones RR; Gelfand EW
    J Allergy Clin Immunol; 2007 Jun; 119(6):1542-5. PubMed ID: 17433830
    [No Abstract]   [Full Text] [Related]  

  • 12. The Jak family tyrosine kinase Jak3 is required for IL-2 synthesis by naive/resting CD4+ T cells.
    Thomis DC; Aramburu J; Berg LJ
    J Immunol; 1999 Nov; 163(10):5411-7. PubMed ID: 10553066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe combined immunodeficiency with absence of peripheral blood CD8+ T cells due to ZAP-70 deficiency.
    Elder ME; Hope TJ; Parslow TG; Umetsu DT; Wara DW; Cowan MJ
    Cell Immunol; 1995 Oct; 165(1):110-7. PubMed ID: 7671314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel JAK3 mutation in a Japanese patient with severe combined immunodeficiency.
    Uchiyama T; Kumaki S; Fujiwara M; Nishida Y; Hakozaki I; Imai K; Du W; Yoshinari M; Sasahara Y; Tsuchiya S
    Pediatr Int; 2005 Oct; 47(5):575-8. PubMed ID: 16190968
    [No Abstract]   [Full Text] [Related]  

  • 15. [Recent progresses in the JAK-STAT signaling pathways].
    Nakajima K
    Nihon Rinsho; 1998 Jul; 56(7):1763-72. PubMed ID: 9702051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Severe combined immunodeficiency disease and similar combined immunodeficiency disease].
    Nakata H; Mitsuya H
    Nihon Rinsho; 2001 Nov; 59 Suppl 7():581-7. PubMed ID: 11808170
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe combined immunodeficiency--molecular pathogenesis and diagnosis.
    Gaspar HB; Gilmour KC; Jones AM
    Arch Dis Child; 2001 Feb; 84(2):169-73. PubMed ID: 11159300
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term survival in severe combined immune deficiency: the role of persistent maternal engraftment.
    Tezcan I; Ersoy F; Sanal O; Turul T; Uckan D; Balci S; Hicsonmez G; Prieur M; Caillat-Zucmann S; Le Deist F; De Saint Basile G
    J Pediatr; 2005 Jan; 146(1):137-40. PubMed ID: 15644840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving transplantation for IL2RG/JAK3 SCID.
    Keller MD
    Blood; 2017 Apr; 129(15):2049-2050. PubMed ID: 28408423
    [No Abstract]   [Full Text] [Related]  

  • 20. Relieving oxidative stress in immune cells.
    Kranc KR; Dzierzak E
    J Exp Med; 2015 Jul; 212(8):1140. PubMed ID: 26216601
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.